E. Serra‐Baldrich - Concepedia

Author

E. Serra‐Baldrich

Also Known As

Driada Preza, E Serra Baldrich, E Serra-Baldrich, E. Serra Baldrich, E. Serra-Baldrich, E. Serra‐Baldrich, Esther S. Baldrich, Esther SERRA-BALDRICH, Esther Serra Baldrich, Esther Serra-Baldrich

199

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Hospital de Sant Pau Wroclaw Medical University University Hospital Münster Medical University of Graz Charité - Universitätsmedizin Berlin

About

E. Serra‐Baldrich is an author at Hospital de Sant Pau specializing in medicine, dermatology, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	1.5K
2	Allergy	15	20	1.1K
3	Allergy Medicine	13	16	952
4	Engineering	1	1	19
5	Public Health	1	1	13

E. Serra‐Baldrich

Publications

Citations

H-Index

Page 1

	Year	Citations
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, Journal of the European Academy of Dermatology and Venereology AsthmaAllergy MedicineImmunodeficienciesAtopic EczemaSkin Allergy	2022	375
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo Manuel P. Pereira, S. Steinke, Claudia Zeidler, Journal of the European Academy of Dermatology and Venereology	2017	246
European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations Andreas Wollenberg, Maria Kinberger, B.W.M. Arents, Journal of the European Academy of Dermatology and Venereology AsthmaNon‐systemic TreatmentsEuroguiderm GuidelineAllergyAtopic Dermatitis	2022	244
Guidelines for diagnosis, prevention, and treatment of hand eczema Jacob P. Thyssen, Marie L. A. Schuttelaar, José Hernán Alfonso, Contact Dermatitis	2021	228
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis Shawn G. Kwatra, Gil Yosipovitch, Franz J. Legat, New England Journal of Medicine	2023	135
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman‐Yassky, British Journal of Dermatology	2023	121
IFSI-guideline on chronic prurigo including prurigo nodularis Sonja Ständer, Manuel P. Pereira, Timothy G. Berger, Itch Chronic PrurigoSclerodermaExpert OpinionMedicineDisease Mechanism	2020	106
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial S. Steinke, Claudia Zeidler, Claudia Riepe, Journal of the American Academy of Dermatology RheumatologyChronic PruritusHumanistic BurdenClinical DermatologyDermatology	2018	89
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria Emek Kocatürk, Andaç Salman, Iván Chérrez-Ojeda, Allergy	2020	88
Pathophysiology and management of sensitive skin: position paper from the special interest group on sensitive skin of the International Forum for the Study of Itch (IFSI) L. Misery, E. Brenaut, Andrea W.M. Evers, Journal of the European Academy of Dermatology and Venereology	2019	77

Page 1